Introduction {#s1}
============

*Plasmodium ovale*, *P. falciparum*, *P. vivax* and *P. malariae* belong to phylum Apicomplexa, order Haemosporidia and family Plasmodiidae. Haemosporidia are intracellular parasites transmitted by haematophagous dipterans. They infect a large variety of vertebrate amniotes, such as mammals (including humans), birds, chelonians, squamates, and crocodilians, [@pone.0005520-Garnham1]. Some are highly pathogenic and may have important implications for human public health, domestic animal health and wildlife biodiversity conservation [@pone.0005520-Guerra1], [@pone.0005520-vanRiper1].

*P. ovale*, the last of the human malaria parasites to be identified, was described in the blood of an East African patient, by Stephens in 1922. It is a relapse parasite, generating secondary infections that are usually asymptomatic [@pone.0005520-Collins1]. However, *P. ovale* may interact with other species of *Plasmodium* infecting humans, such as *P. falciparum* and *P. vivax*, and may have a major influence on the epidemiological features of malaria [@pone.0005520-Mueller1].

Few epidemiological data are available for *P. ovale*. Its reported prevalence is generally low (\<5%), except in West Africa, where prevalences above 10% have been observed in humans [@pone.0005520-Cornu1], [@pone.0005520-Faye1]. *P. ovale* is often present in mixed infections and parasitaemia is usually low.

*P. ovale* was previously thought to be present only in sub-Saharan Africa, Papua New Guinea, Irian Jaya in Indonesia and the Philippines [@pone.0005520-Collins1]. However, it appears to be more widely distributed, having been reported in the Middle East, the Indian Subcontinent and various parts of Southeast Asia [@pone.0005520-Cadigan1]--[@pone.0005520-Incardona1]. *P. ovale* has not been yet reported in South America. However, no global map of the geographical distribution of *P. ovale* has been produced since that of Lysenko and Beljaev in 1969 [@pone.0005520-Lysenko1].

Few studies document the molecular diversity, geographical origin, evolutionary history and age of *P. ovale* populations. Based on complete DNA sequences of the small subunit ribosomal RNA (*SSUrRNA*) gene, partial sequences of cysteine protease, ookinete surface protein and *cytochrome b* genes, Win et al. (2004) compared *P. ovale* isolates from Myanmar, Indonesia and sequences available from GenBank. The result obtained supported the division of *P. ovale* into at least two types, but the classical and variant types identified did not differ morphologically and occurred in sympatry [@pone.0005520-Win1], [@pone.0005520-Tachibana1].

Phylogenetically, *P. ovale* clusters with *Plasmodium* species affecting simian primates (as do *P. malariae* and *P. vivax*, but not *P. falciparum*), but its phylogenetic relationships to other *Plasmodium* species or haemosporidian parasite genera remain unclear [@pone.0005520-Collins1].

Three *Plasmodium* species, *P. reichenowi*, *P. schwetzi* and *P. rodhaini*, have already been reported in African great apes (chimpanzees and gorillas) and have been described as morphologically similar to *P. falciparum*, *P. ovale* or *P. vivax* (there are differing opinions) and *P. malariae*, respectively [@pone.0005520-Coatney1]. Like humans, the African great apes belong to the Hominidae family. Despite the close phylogenetic relationships between these non human primates and human hosts, the diversity of *Plasmodium* parasites in African great apes has been little studied and few molecular data for these parasites are available. Indeed, only one strain of *P. reichenowi*, originally isolated from a naturally infected chimpanzee (*Pan troglodytes*) in Central Africa (East of the Democratic Republic of the Congo) and adapted to a laboratory splenectomized chimpanzee, has been molecularly characterized [@pone.0005520-Coatney1]. This parasite is closely phylogenetically related to *P. falciparum*, the principal cause of human malaria. Data for other taxa, including genetically characterized non human primate malaria parasites, are required to provide insight into the evolutionary history of *P. ovale* [@pone.0005520-Hagner1].

In order to investigate the diversity of *Plasmodium* parasites in African great apes, we screened 130 DNA samples from chimpanzees and gorillas in Cameroon. We found three chimpanzees infected by *Plasmodium* related to the human *P. ovale*. We present here the diversity of these chimpanzee parasites using two mitochondrial and one nuclear partial gene sequences and compared them to human *P. ovale* strains.

Results {#s2}
=======

DNA samples from 130 chimpanzees and gorillas were tested for *Plasmodium* infection, using *cytochrome b* molecular tools. Two chimpanzees, CPZcam89 (225) and CPZcam91 (451), both belonging to subspecies *Pan t*. *troglodytes*, presented a single infection with *Plasmodium* parasites phylogenetically related to *P. ovale*. Both *Plasmodium* isolates were characterized by a unique DNA sequence for each of the *cox1*, *cyt b* and *ldh* markers, differing between the two isolates. A third chimpanzee (CPZcam63 (2360)), belonging to subspecies, *Pan t*. *vellerosus*, had a mixed infection composed of *P. reichenowi* and *P. ovale* related parasites. The latter has an identical *cyt b* sequence to *Plasmodium* found in CPZcam89 (451) chimpanzee; this isolate was discarded from the phylogenetic construction. The prevalence of *P. ovale* related *Plasmodium* species was found to be 2.3% (3/130) in the Cameroonian great apes tested. This prevalence is comparable to the prevalence of *P. ovale* in human populations from most endemic areas (\<5%).

The 708 bp *cyt b* and the 964 bp *cox1* sequences as well as the 350 bp *ldh* sequence of the CPZcam89 (225) chimpanzee parasite strain are all identical to the human *P. ovale* variant type sequences ([Tables 1](#pone-0005520-t001){ref-type="table"}, [2](#pone-0005520-t002){ref-type="table"} and [3](#pone-0005520-t003){ref-type="table"}). Based on this genetic homology, this chimpanzee parasite strain was identified as being of the *P. ovale* variant type. The *cyt b*, *cox1* and *ldh* nucleotide sequences of the CPZcam91 (451) chimpanzee parasite diverged from the reported classical and variant *P. ovale* type nucleotide sequences ([Tables 1](#pone-0005520-t001){ref-type="table"}, [2](#pone-0005520-t002){ref-type="table"} and [3](#pone-0005520-t003){ref-type="table"}). For the *cyt b* marker, this chimpanzee *Plasmodium* sequence presented four synonymous mutations with respect to the classical *P. ovale* type sequence and one non synonymous mutation, M248I, with respect to the variant *P. ovale* type sequence ([Table 1](#pone-0005520-t001){ref-type="table"}). The *cox1* marker displayed two non synonymous mutations with respect to the classical *P. ovale* type and three with respect to the variant *P. ovale* type ([Table 2](#pone-0005520-t002){ref-type="table"}). The nuclear *ldh* sequence shows two non synonymous mutations compared to the classical *P. ovale* and four non synonymous mutations compared to the variant *P. ovale* ([Table 3](#pone-0005520-t003){ref-type="table"}).

10.1371/journal.pone.0005520.t001

###### Substitutions and their positions in *cyt b* nucleotide sequences (numbers correspond to base pair positions and were defined according to the complete *P. falciparum cyt b* gene sequence M76611).

![](pone.0005520.t001){#pone-0005520-t001-1}

  Sequences                    315   375   402   450   492   510   514   534     744     756   774   885   903   948
  --------------------------- ----- ----- ----- ----- ----- ----- ----- ----- --------- ----- ----- ----- ----- -----
  *P. ovale* classical type    \-    \-    \-    \-    \-    \-    \-    \-      \-      \-    \-    \-    \-    \-
  *P. ovale* variant type      \-     A     T    \-     A    \-    \-     T       T       T     A     T     T     A
                                                                               (M248I)                          
  CPZcam89 (225)               \-     A     T    \-     A    \-    \-     T       T       T     A     T     T     A
                                                                               (M248I)                          
  CPZcam91 (451)                A    \-    \-     A    \-     T     T    \-      \-      \-    \-    \-    \-    \-

Non synonymous mutation is shown in brackets.

10.1371/journal.pone.0005520.t002

###### Substitutions and their positions in *cox1* nucleotide sequences (numbers correspond to base pair positions and were defined according to the complete sequence of the *P. falciparum cox1* gene M76611).
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  Sequences                    449   458   462   473   575     632     650   657   761     764       765     766   830   966   1016   1022   1082
  --------------------------- ----- ----- ----- ----- ----- --------- ----- ----- ----- --------- --------- ----- ----- ----- ------ ------ ------
  *P. ovale* classical type    \-    \-    \-    \-    \-      \-      \-    \-    \-      \-        \-      \-    \-    \-     \-     \-     \-
  *P. ovale* variant type       C     C     T     T     G       A      \-     T    \-      \-        \-      \-     T     G     \-     \-     A
                                                             (M211I)                                                                        
  CPZcam89 (225)                C     C     T     T     G       A      \-     T    \-      \-        \-      \-     T     G     \-     \-     A
                                                             (M211I)                                                                        
  CPZcam91 (451)               \-    \-     T    \-    \-      \-       G    \-     A       T         A       C    \-    \-     A      T      A
                                                                                         (L255F)   (H256T)                                  

Non synonymous mutations are shown in brackets.

10.1371/journal.pone.0005520.t003

###### Substitutions and their positions in *ldh* nucleotide sequences (numbers correspond to base pair positions and were defined according to the complete sequence of the *P. falciparum ldh* gene PF13_0141).

![](pone.0005520.t003){#pone-0005520-t003-3}

  Sequences                    195   237   243   258   291   301   321   333     337     339
  --------------------------- ----- ----- ----- ----- ----- ----- ----- ----- --------- -----
  *P. ovale* classical type    \-    \-    \-    \-    \-    \-    \-    \-      \-      \-
  *P. ovale* variant type       C     A     C     A    \-     C     C    \-      \-       T
                                                                                        
  CPZcam89 (225)                C     A     C     A    \-     C     C    \-      \-       T
                                                                                        
  CPZcam91 (451)               \-    \-    \-    \-     T    \-    \-     T       G      \-
                                                                               (I113V)  

  Sequences                    351     361     387   406     427     475     504     507   510
  --------------------------- ----- --------- ----- ----- --------- ----- --------- ----- -----
  *P. ovale* classical type    \-      \-      \-    \-      \-      \-      \-      \-    \-
  *P. ovale* variant type      \-      \-      \-     C       C       T       G       A     C
                                                           (S143P)         (K168N)        
  CPZcam89 (225)               \-      \-      \-     C       C       T       G       A     C
                                                           (S143P)         (K168N)        
  CPZcam91 (451)                T       C       T    \-      \-      \-      \-       G     C
                                     (F121L)                                              

Non synonymous mutations are shown in brackets.

Investigation of the mitochondrial *cyt b*, *cox1* and nuclear *ldh* partial gene sequences in 13 *P. ovale* strains from humans from 12 different sites showed that *P. ovale* species could be divided into two distinct groups. Both classical and variant *P. ovale* ([Table 4](#pone-0005520-t004){ref-type="table"}) were associated with a unique sequence for each marker, consistent with the finding of Win et al, 2004 on *cyt b* gene [@pone.0005520-Win1], [@pone.0005520-Talman1]. Comparisons of *cyt b* nucleotide sequences revealed 10 different substitutions between the variant and classical *P. ovale* types, one of which was a non synonymous mutation, M248I ([Table 1](#pone-0005520-t001){ref-type="table"}). Comparisons of the classical and variant *cox1* nucleotide sequences, also revealed 10 different mutations, one of which was a non synonymous mutation M211I ([Table 2](#pone-0005520-t002){ref-type="table"}). Comparisons of *ldh* classical and variant *P. ovale* nucleotide sequences showed 13 different substitutions, two of which were non synonymous mutations, S143P and K168N ([Table 3](#pone-0005520-t003){ref-type="table"}).

10.1371/journal.pone.0005520.t004

###### Human *P. ovale* strains, strain code, geographical location of origin, nucleotide sequence, type and GenBank accession number.

![](pone.0005520.t004){#pone-0005520-t004-4}

  Species       Strain code              Origin              GenBank accession number *cytb*   GenBank accession number *cox1*     Type
  ------------ ------------- ------------------------------ --------------------------------- --------------------------------- -----------
  *P. ovale*       5894                  Angola                         FJ409567                          FJ409571               classical
  *P. ovale*       CAMBO                Cambodia                        FJ409567                          FJ409571               classical
  *P. ovale*       3044        Republic of Central Africa               FJ409567                          FJ409571               classical
  *P. ovale*       5979               Ivory Coast                       FJ409567                          FJ409571               classical
  *P. ovale*       3149                  Gabon                          FJ409567                          FJ409571               classical
  *P. ovale*       4646                  Guinea                         FJ409567                          FJ409571               classical
  *P. ovale*       3740       Democratic Republic of Congo              FJ409567                          FJ409571               classical
  *P. ovale*       4419                 Cameroon                        FJ409566                          FJ409570                variant
  *P. ovale*       5401                Madagascar                       FJ409566                          FJ409570                variant
  *P. ovale*       2132                   Mali                          FJ409566                          FJ409570                variant
  *P. ovale*       5994                   Mali                          FJ409566                          FJ409570                variant
  *P. ovale*       2668                  Rwanda                         FJ409566                          FJ409570                variant
  *P. ovale*       3043                 Zimbabwe                        FJ409566                          FJ409570                variant

The sequences presented are derived from a single PCR-sequencing event. The differences observed between these sequences, though likely to reflect reality, might be the result of PCR amplification artefacts.

Both of the methods used, maximum likelihood (ML) and Bayesian analyses, produced the same tree topology consistent with previous published *Plasmodium* phylogenetic analysis [@pone.0005520-Escalante1], [@pone.0005520-Hayakawa1]. The phylogenetic relationships between the two *Plasmodium* strains isolated from chimpanzees to classical and variant *P. ovale* types, and the position of these strains within primate parasite group, are presented in [Figure 1](#pone-0005520-g001){ref-type="fig"}. The two chimpanzee parasites formed a monophyletic group with the two human *P. ovale* types. Monophyly was well supported by Bayesian posterior probabilities of 0.98 and a bootstrap value of 94%.

![Phylogeny of Haemosporidia inferred from *cyt b* and *cox1* nucleotide sequences.\
Values are bootstrap percentages obtained by maximum likelihood analysis (left of the slash, values under 70% not shown) and Bayesian posterior probabilities (right of the slash, values less then 0.7 not shown), *P*. = *Plasmodium*. In red: Human malaria parasite species. Usual hosts are presented on the right side.](pone.0005520.g001){#pone-0005520-g001}

Discussion {#s3}
==========

The characterization of 13 *P. ovale* human isolates, using mitochondrial *cyt b* and *cox1* markers and nuclear *ldh* marker from 12 different geographical locations, confirmed the diversification of human strains of *P. ovale* into two types, classical and variant [@pone.0005520-Win1].

We reported here the first molecular finding of three chimpanzee *Plasmodium* isolates, one (CPZcam89 (225)) genetically identical to *P. ovale* variant type, one other (CPZcam91 (451)) closely related to human *P. ovale* types and a third one (CPZcam63 (2360)) showing mixed infection composed of *P. reichenowi* and *P. ovale* related parasite (the latter exhibits an *cyt b* sequence identical to CPZcam91 (451) *cyt b* sequence parasite). Phylogenetic analyses inferred from *cyt b* and *cox1* concatenates are well supported and show a monophyletic group composed of human *P. ovale* types and related chimpanzee parasites. The monophyly of the group is confirmed using *ldh* nuclear partial gene sequences (data not shown).

*P. schwetzi* has been originally described by Reichenow in 1920 in blood apes in Cameroon [@pone.0005520-Coatney1]. *P. schwetzi* is morphologically similar to both *P. vivax* and *P. ovale* parasites that infect humans, and to date there are two equally convincing arguments to favour one or the other of these species as the most closely related to *P. schwetzi* [@pone.0005520-Coatney1]. Experimental infections by *P. schwetzi* in humans have also been reported [@pone.0005520-Rodhain1] and in 1970, Contacos established its potential as a zoonosis for Africa [@pone.0005520-Contacos1]. At present, no isolate of this parasite from which molecular sequences can be obtained is available.

*P. schwetzi* often occurs as a mixed infection with *P. reichenowi* and *P. rodhaini*, the two other African great ape *Plasmodium* species described morphologically similar to *P. falciparum* and *P. malariae* respectively. In this study, we found one chimpanzee co-infected with *P. reichenowi* and a *P. ovale* related parasite molecularly identical to CPZcam91 (451) isolate. The CPZcam91 (451) chimpanzee parasite might be identified as being *P. schwetzi* regarding reports available on this species. Nevertheless, there is not enough evidence to support this. Morphological and other molecular information are needed to establish the identity of this parasite.

The identical sequences of CPZcam89 (225) chimpanzee parasite strain to the *P. ovale* variant type on both mitochondrial *cyt b* and *cox1* and nuclear *ldh* markers suggest possible cross-species transmission between human and chimpanzee hosts in Cameroon. Interestingly, a prevalence of *P. ovale* higher than that usually reported in Africa (above 10%) has been reported in two villages in the Manyemen forest province in Cameroon, where humans and great apes live in sympatry [@pone.0005520-Cornu1]. Furthermore, earlier, Lysenko and Beljaev (1969) previously reported a close relationship between *P. ovale* prevalence in humans and proximity to great apes in Africa [@pone.0005520-Lysenko1].

No direct evidence for human malaria parasite transmission between apes and humans was reported in Gabon [@pone.0005520-Ollomo1], but natural transmissions of human malaria parasites to non human primates have been reported in South America. *P. falciparum*, *P. vivax* and *P. malariae* transmissions to wild monkeys of the rainforest in French Guyana [@pone.0005520-Fandeur1] and to Brazilian wild monkeys [@pone.0005520-deCastroDuarte1] have also been documented. Experimental transmission of *P. ovale* to chimpanzees via sporozoite inoculation has been reported [@pone.0005520-Bray1].

This study provides the first evidence of human *P. ovale* variant type in chimpanzees in Cameroon. A large molecular epidemiology study would be required to improve the documentation of potential natural bidirectional transmission between chimpanzee and human populations living in sympatry, making it possible to evaluate the potential role of African great apes as a reservoir for *P. ovale* in West Africa. The question raised by Haydon et al. (2002) concerning the possibility of human *Plasmodium* species being permanently maintained in chimpanzee populations, from which infection is transmitted to human, remains to be explored [@pone.0005520-Haydon1].

Materials and Methods {#s4}
=====================

Chimpanzee and gorilla DNA specimens {#s4a}
------------------------------------

Chimpanzees and gorillas, originated from different areas of Cameroon, were, for the most part, initially kept as pets for a variable period of time and then either brought to the local zoos or sanctuaries or confiscated by the Ministry of Environment and Forestry, then gathered in captivity. These animals were sampled and included during virological studies lead by the Virology Unit of Centre Pasteur du Cameroon [@pone.0005520-Macfie1], [@pone.0005520-Calattini1]. A DNA bank was constituted between 1998 and 2004.

In total, we tested 130 DNA samples from great apes for *Plasmodium* infection, using *cytochrome b* (*cyt b*) molecular tools: 105 chimpanzees from 4 subspecies (60 *Pan t*. *troglodytes*, 39 *Pan t*. *vellerosus*, 3 *Pan t*. *schweinfurthii* and 3 *Pan t*. *verus*), 8 chimpanzees of undetermined subspecies and 17 gorillas (*Gorilla gorilla*).

Detailed information on the three positive samples: CPZcam89 (225): *Pan t*. *troglodytes* subspecies, juvenile female, collected in February 2000; CPZcam 91 (451): *Pan t*. *troglodytes* subspecies, adult male, collected in February 2001; CPZcam63 (2360): *Pan t*. *vellerosus* subspecies, adult male, collected in September 1998.

*Cyt b* PCR amplification {#s4b}
-------------------------

We amplified 708 bp *Cyt b* gene fragments with two sets of primers, one for PCR reaction, PLAS1 (5′-GAGAATTATGGAGTGGATGGTG-3′) and PLAS2a (5′-GTGGTAATTGACATCCWATCC-3′) and one for nested-PCR, PLAS3 (5′-GGTGTTTYAGATAYATGCAYGC-3′) and PLAS4 (5′-CATCCWATCCATARTAWAGCATAG-3′) [@pone.0005520-Duval1].

These primers are specifics for Haemosporidia parasites and do not amplify DNA from other Apicomplexa parasites or host DNA. PCR and nested-PCR were carried out in a final volume of 25 μl, under the following conditions: 2.5 μl of each primer (10 pmol/μl), 2 mM of each dNTP, 0.5 U of *Taq* polymerase (Solis), 2 mM MgCl~2~ and 2 μl of DNA, heating for 5 minutes at 94°C, 30 s at 94°C, 30 s at 55°C and 1 min 30 s at 72°C for 40 cycles and a final extension phase for 10 minutes at 72°C. The PCR products were sequenced by Macrogen (Korea) using PLAS3 and PLAS4 primers.

The parasites isolated from African great apes were also characterized molecularly by another gene, the *cytochrome c oxidase 1* gene (*cox1*). This mitochondrial gene has been chosen for the international barcoding programme for biodiversity identification [@pone.0005520-Hajibabaei1]. Like *cyt b*, it is a conserved gene and is useful for resolving phylogenetic relationships between populations of parasite species that have diverged over tens or hundreds of millions of years [@pone.0005520-Perkins1], [@pone.0005520-Martinsen1].

*Cox1* PCR amplification {#s4c}
------------------------

We amplified 964 bp *Cox1* gene fragments with the PCR primer set, *cox1a*: 5′-CGCCTGACATGGATGGATAATAC -3′ and *cox1b*: 5′-CCATTTAAAGCGTCTGGATAATC -3′ and the nested-PCR primer set, *cox1c*: 5′-GATTAACCGCTGTCGCTGGGACTG -3′ and *cox1d*: 5′-CGTCTAGGCATTACATTAAATCC -3′.

These primers are specifics of Haemosporidia parasites and do not amplify DNA from other Apicomplexa parasites or host DNA. PCR and nested-PCR were carried out in a final volume of 25 μl, under the following conditions: 2.5 μl of each primer (10 pmol/μl), 2 mM of each dNTP, 0.5 U of *Taq* polymerase (Solis), 1.5 mM MgCl~2~ and 2 μl of DNA, 5 minutes at 94°C, 30 s at 94°C, 30 s at 53°C for PCR and 30 s at 58°C for nested-PCR, and 2 minutes at 72°C for 40 cycles, with a final extension period of 10 minutes at 72°C. The PCR products were sequenced by Macrogen (Korea) using *cox1c* and *cox1d* primers.

The nuclear lactate dehydrogenase (*ldh*) gene has also been used to characterize parasites isolated from chimpanzees.

*Ldh* PCR amplification {#s4d}
-----------------------

We amplified 350 bp *ldh* gene fragments with two sets of primers, one for PCR reaction, LDH1 (5′-GGNTCDGGHATGATHGGAGG-3′) and LDH2 (5′-GCCATTTCRATRATDGCAGC-3′) and one for nested-PCR, LDH7 (5′-TGTDATGGCWTAYTCVAATTGYMARGT-3′) and LDH8 (5′-CCATYTTRTTNCCATGWGCWSCDACA-3′) [@pone.0005520-Talman1].

These primers are specifics for Haemosporidia parasites and do not amplify DNA from other Apicomplexa parasites or host DNA. PCR and nested-PCR were carried out in a final volume of 25 μl, under the following conditions: 2.5 μl of each primer (10 pmol/μl), 2 mM of each dNTP, 0.5 U of *Taq* polymerase (Solis), 2,5 mM MgCl~2~ and 2 μl of DNA ,heating for 5 minutes at 94°C, 30 s at 94°C, 30 s at 55°C for PCR and 30s at 52°C for nested-PCR, and 1min at 72°C for 40 cycles and a final extension phase for 10 minutes at 72°C. The PCR products were sequenced by Macrogen (Korea) using LDH7 and LDH8 primers.

*P. ovale* human strains {#s4e}
------------------------

We also characterized *P. ovale* from 12 isolates collected from 11 different African locations and 1 isolate collected from South-East Asia, Cambodia ([Table 4](#pone-0005520-t004){ref-type="table"}), in collaboration with the National Reference Center for Malaria (AP-HP, Hôpital Bichat-Claude Bernard, Paris, France) using the *cyt b*, *cox1* and *ldh* partial gene sequences.

Phylogenetic analyses {#s4f}
---------------------

The *cyt b*, *cox1* and *ldh* sequences were checked using chromatograms and CLUSTALW alignment to ensure that none of the positions was ambiguous [@pone.0005520-Thompson1]. Mixed infection was discarded from the phylogenetic study. Phylogenetic analyses were based on the use of 708 bp *cyt b* and 964 bp *cox1* concatenated sequences ([Table 5](#pone-0005520-t005){ref-type="table"}). Reference sequences without ambiguous positions for either *cyt b* or *cox1* were retrieved from GenBank.

10.1371/journal.pone.0005520.t005

###### Parasite taxa, with host name, geographical location and GenBank accession number of the *cyt b* and *cox1* sequences used for the phylogenetic analysis

![](pone.0005520.t005){#pone-0005520-t005-5}

  Parasites                              Host                  Geographical location         GenBank accession number *cyt b*   GenBank accession number *cox1*
  --------------------------- -------------------------- ---------------------------------- ---------------------------------- ---------------------------------
  *P. falciparum*                   *Homo sapiens*                Tropical regions                        M76611                            M76611
  *P. gonderi*                    Old World monkeys                Central Africa                        AY800111                          AY800111
  *P. knowlesi*                   Old World monkeys                   Malaysia                           AY598141                          AY598141
  *P. malariae*                     *Homo sapiens*        Tropical and subtropical regions               AF069624                          AF182848
  *P. vivax*                        *Homo sapiens*        Tropical and subtropical regions               AY598139                          AY598139
  *P. simiovale*                  Old World monkeys                     Asia                             AY800109                          AY800109
  *P. simium*                     New World monkeys                South America                         AY800110                          AY800110
  *P. cynomolgi*                  Old World monkeys                Southeast Asia                        AY800108                          AY800108
  *P. ovale* classical              *Homo sapiens*                Tropical regions                       FJ409567                          FJ409571
  *P. ovale* variant                *Homo sapiens*                Tropical regions                       FJ409566                          FJ409570
  CPZcam89 (225)                 *Pan t. troglodytes*             Tropical regions                       FJ409565                          FJ409569
  CPZcam91 (451)                 *Pan t. troglodytes*             Tropical regions                       FJ409564                          FJ409568
  *P. yoelii*                    *Thamnomys rutilans*              Central Africa                         M29000                            M29000
  *P. berghei*                  *Grammomys surdaster*              Central Africa                        AF014115                          AF014115
  *P. chabaudi*                  *Thamnomys rutilans*              Central Africa                        AF014116                          AF014116
  *P. gallinaceum*                 *Gallus gallus*                    Vietnam                            AB250690                          AB250690
  *P. relictum*                         Birds                      North America                         AY099032                          EU254593
  *P. juxtanucleare*               *Gallus gallus*                      Asia                             AB250415                          AB250415
  *Leucocytozoon caulleryi*             Birds                     Tropical regions                       AB302215                          AB302215
  *Haemoproteus sp.*           *Lichenostomus frenatus*              Australia                           AY733087                          AY733087

Statistical analysis, based on the Xia and Xie method, was conducted to examine whether the number of substitutions was saturated or not [@pone.0005520-Xia1]. In this method, both transitions and transversions were plotted against evolutionary distances calculated with the JC69 model. The relative rates at which transitions and transversions saturated at the third position were compared by counting substitutions in all pairwise comparisons between sequences. The analysis showed that the third base was saturated, and this base was therefore discarded for subsequent phylogenetic analyses.

We identified the most appropriate nucleotide substitution model, based on hierarchical likelihood ratio tests (hLRTs), Akaike Information criterion (AIC) and bayesian information criterion (BIC) values, using PHYML [@pone.0005520-Guindon1] in a similar way to Modeltest [@pone.0005520-Posada1]. The Hasegawa, Kishino and Yano statistic HKY [@pone.0005520-Hasegawa1] was favoured by the hLRT and BIC tests. Rate variation between sites was allowed, with a gamma distribution for four rate categories for the nucleotide and amino acid data, allowing for invariant sites. Maximum likelihood and Bayesian trees were inferred using the previously described model. Maximum likelihood (ML) analysis was carried out with Phyml [@pone.0005520-Guindon2], with nodal robustness evaluated by non-parametric bootstrapping (1000 replicates). Bayesian analysis was performed with MrBayes [@pone.0005520-Huelsenbeck1], using two runs of 1 million generations sampled every 100 generations. Convergence was determined using the standard deviation of the split frequencies and runs were stopped when a value of less than 0.01 was reached. The burn in phase was defined as the first 250,000 generations.
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